क्यूआर कोड

Intranasal HD-Ad vaccine protects the upper and lower respiratory tracts of hACE2 mice against SARS-CoV-2

Abstract Background The ongoing COVID-19 pandemic has resulted in 185 million recorded cases and over 4 million deaths worldwide. Several COVID-19 vaccines have been approved for emergency use in humans and are being used in many countries. However, all the approved vaccines are administered by intr...

पूर्ण विवरण

में बचाया:
मुख्य लेखकों: Huibi Cao, Juntao Mai, Zhichang Zhou, Zhijie Li, Rongqi Duan, Jacqueline Watt, Ziyan Chen, Ranmal Avinash Bandara, Ming Li, Sang Kyun Ahn, Betty Poon, Natasha Christie-Holmes, Scott D. Gray-Owen, Arinjay Banerjee, Karen Mossman, Rob Kozak, Samira Mubareka, James M. Rini, Jim Hu, Jun Liu
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: BMC 2021-12-01
श्रृंखला:Cell & Bioscience
विषय:
COVID-19
HD-Ad
Nasal delivery
SARS-CoV2
Vaccine
ऑनलाइन पहुंच:https://doi.org/10.1186/s13578-021-00723-0
टैग: टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन